Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed by a doctor with a type of scarring lung disease (called interstitial lung disease or ILD), confirmed using standard medical guidelines
- You have had a persistent cough lasting more than 8 weeks
Who may not be able to join:
- You regularly cough up moderate or large amounts of mucus or phlegm
- Your lung condition has gotten worse, or is suspected to have gotten worse, in the past month
- You have had a cold, flu, or other upper respiratory infection in the past month
- You are currently taking a type of blood pressure medication called an ACE inhibitor (confirm with trial site if unsure whether your medication falls into this category)
- Any of your prescribed medications have been changed in the past month
- A detailed lung scan (called an HRCT) has shown a specific type of airway damage called traction bronchiectasis
- You have another health condition that would prevent you from taking part in an exercise program
- You are unable to read or speak English, or are unable to give your own informed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 6477651525
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of intervention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.